Industry News

September 2, 2010

Submit your candidate for the Fierce 15

September 2, 2010

Antibiotic gets positive FDA staff assessment

September 2, 2010

Analysts: New FDA rules inspire tougher drug reviews

September 2, 2010

Nobel Prize-winner finds new path for Alzheimer's drug

September 2, 2010

Genzyme dickers over sales deals as Sanofi dangles

September 2, 2010

Cardiome shares jump after vernakalant OK triggers $30M milestone

September 2, 2010

Orexigen and Takeda ink a billion-dollar pact on weight loss drug

September 1, 2010

Last call: Deadline looms for 2010 Fierce 15

September 1, 2010

Theratechnologies names Huss president, CEO

September 1, 2010

Celator gains $20M round for cancer drug dev

September 1, 2010

Archimedes snags EMA approval for new pain therapy

September 1, 2010

Pfizer buys FoldRx for rare disease division

September 1, 2010

Cellerant lands $153M BARDA contract for ARS program

September 1, 2010

PhIII: Liver enzymes spike in 7% of mipomersen group

September 1, 2010

Termeer insists Genzyme is worth much more than $18.5B

August 31, 2010

Bayer, Kythera ink $373M dermatology deal

August 31, 2010

Achaogen wins $64M biodefense contract

August 31, 2010

AMT looks for funding while it waits for EMA approval

August 31, 2010

Endo looks for more acquisitions

August 31, 2010

Apixaban, Xarelto deliver good results in studies

August 30, 2010

Genzyme rejects Sanofi's $18.5B offer

August 30, 2010

Eisai heart drug may lower heart risks

August 30, 2010

FDA wants more data on AZ's motavizumab

August 30, 2010

Otonomy lands $38.5M for ear disorder work

August 30, 2010

ImmunoSolv merges to avoid 'one trick pony' syndrome

August 30, 2010

Top 10 Women in Biotech

August 30, 2010

Novartis set to begin late-stage testing of blood thinner

August 30, 2010

Top 10 Women in Biotech

August 30, 2010

Katrine Bosley – Top 10 Women in Biotech

August 30, 2010

Susan Desmond-Hellman – Top 10 Women in Biotech